Current treatment landscape and translational priorities in malignant rhabdoid tumor of the kidney - Quiz - MDSpire

Current treatment landscape and translational priorities in malignant rhabdoid tumor of the kidney

  • By

  • Zhigang Yao

  • Chenghao Zhanghuang

  • Nian Zhou

  • Jinrong Li

  • Zipeng Hao

  • Bing Yan

  • Hui Zhao

  • June 10, 2026

  • 0 min

Share

Original Source(s)

Current treatment landscape and translational priorities in malignant rhabdoid tumor of the kidney

  • by Zhigang Yao, Chenghao Zhanghuang, Nian Zhou, Jinrong Li, Zipeng Hao, Bing Yan, Hui Zhao

  • June 10, 2026

Related Content

Correction: Phase I/II, open-label, multicenter study of durvalumab in combination with tremelimumab in pediatric patients with advanced solid tumors

Multidisciplinary team care and outcomes in FNCLCC grade 3 soft tissue sarcoma: a propensity score–matched and weighted cohort study

Clinical utility of an optoelectronic imaging tracing system for diagnosis of high-grade cervical lesions